Shipra Malik

514 total citations
17 papers, 353 citations indexed

About

Shipra Malik is a scholar working on Molecular Biology, Cancer Research and Infectious Diseases. According to data from OpenAlex, Shipra Malik has authored 17 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Cancer Research and 1 paper in Infectious Diseases. Recurrent topics in Shipra Malik's work include RNA Interference and Gene Delivery (13 papers), Advanced biosensing and bioanalysis techniques (12 papers) and DNA and Nucleic Acid Chemistry (6 papers). Shipra Malik is often cited by papers focused on RNA Interference and Gene Delivery (13 papers), Advanced biosensing and bioanalysis techniques (12 papers) and DNA and Nucleic Acid Chemistry (6 papers). Shipra Malik collaborates with scholars based in United States, Brazil and United Kingdom. Shipra Malik's co-authors include Raman Bahal, Frank J. Slack, Demetrios T. Braddock, Jihoon Lim, Mu‐Ping Nieh, Carlos Fernández‐Hernando, Mehran M. Sadeghi, Yajaira Suárez, Yana K. Reshetnyak and Noemí Rotllán and has published in prestigious journals such as Advanced Functional Materials, Circulation Research and ACS Applied Materials & Interfaces.

In The Last Decade

Shipra Malik

17 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shipra Malik United States	12	255	93	45	32	28	17	353
Lesley Jenkinson United Kingdom	5	248 1.0×	143 1.5×	46 1.0×	46 1.4×	25 0.9×	6	301
Tuyen Nguyen United States	10	468 1.8×	112 1.2×	103 2.3×	26 0.8×	23 0.8×	14	623
Meichen Liu China	10	156 0.6×	39 0.4×	59 1.3×	45 1.4×	16 0.6×	31	267
Fahimeh Fattahi Iran	11	186 0.7×	95 1.0×	42 0.9×	34 1.1×	19 0.7×	28	338
Haimei Tang China	13	190 0.7×	43 0.5×	54 1.2×	14 0.4×	13 0.5×	25	313
Chang-Meng Wu China	10	180 0.7×	74 0.8×	80 1.8×	54 1.7×	6 0.2×	13	323
Anna Drożdż Poland	9	250 1.0×	121 1.3×	50 1.1×	45 1.4×	22 0.8×	14	344
Yilin Wang China	8	138 0.5×	85 0.9×	70 1.6×	54 1.7×	5 0.2×	24	344
Olja Mijanović Russia	7	134 0.5×	57 0.6×	26 0.6×	31 1.0×	22 0.8×	9	268
Chuanfei Li China	9	191 0.7×	87 0.9×	19 0.4×	43 1.3×	21 0.8×	20	287

Countries citing papers authored by Shipra Malik

Since Specialization

Citations

This map shows the geographic impact of Shipra Malik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shipra Malik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shipra Malik more than expected).

Fields of papers citing papers by Shipra Malik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shipra Malik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shipra Malik. The network helps show where Shipra Malik may publish in the future.

Co-authorship network of co-authors of Shipra Malik

This figure shows the co-authorship network connecting the top 25 collaborators of Shipra Malik. A scholar is included among the top collaborators of Shipra Malik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shipra Malik. Shipra Malik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Malik, Shipra, Vikas Kumar, Yong Xiao, et al.. (2024). Antitumor efficacy of a sequence-specific DNA-targeted γPNA-based c-Myc inhibitor. Cell Reports Medicine. 5(1). 101354–101354. 7 indexed citations

Kumar, Vikas, et al.. (2024). Enhancing RNA inhibitory activity using clamp-G-modified nucleobases. Cell Reports Physical Science. 5(8). 102120–102120. 2 indexed citations

Wang, Yazhe, Shipra Malik, Hee‐Won Suh, et al.. (2023). Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy. Science Advances. 9(6). eabq7459–eabq7459. 26 indexed citations

Malik, Shipra, et al.. (2023). Unlocking the potential of chemically modified peptide nucleic acids for RNA-based therapeutics. RNA. 29(4). 434–445. 23 indexed citations

Zhang, Xinbo, Noemí Rotllán, Alberto Canfrán‐Duque, et al.. (2022). Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis Regression. Circulation Research. 131(1). 77–90. 52 indexed citations

Malik, Shipra, W. Mark Saltzman, & Raman Bahal. (2021). Extracellular vesicles mediated exocytosis of antisense peptide nucleic acids. Molecular Therapy — Nucleic Acids. 25. 302–315. 12 indexed citations

Wahane, Aniket, Shipra Malik, Kuo‐Chih Shih, et al.. (2021). Dual-Modality Poly-l-histidine Nanoparticles to Deliver Peptide Nucleic Acids and Paclitaxel for In Vivo Cancer Therapy. ACS Applied Materials & Interfaces. 13(38). 45244–45258. 19 indexed citations

Malik, Shipra, Vikas Kumar, Kuo‐Chih Shih, et al.. (2021). Head on Comparison of Self‐ and Nano‐Assemblies of Gamma Peptide Nucleic Acid Amphiphiles. Advanced Functional Materials. 32(7). 13 indexed citations

Malik, Shipra, Jihoon Lim, Frank J. Slack, Demetrios T. Braddock, & Raman Bahal. (2020). Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles. Journal of Controlled Release. 327. 406–419. 39 indexed citations

10.

Malik, Shipra, Frank J. Slack, & Raman Bahal. (2020). Formulation of PLGA nanoparticles containing short cationic peptide nucleic acids. MethodsX. 7. 101115–101115. 11 indexed citations

11.

Malik, Shipra, Anisha Gupta, Xiao‐bo Zhong, et al.. (2020). Emerging Therapeutic Modalities against COVID-19. Pharmaceuticals. 13(8). 188–188. 18 indexed citations

12.

Price, Nathan L., Verónica Miguel, Wen Ding, et al.. (2019). Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis. JCI Insight. 4(22). 53 indexed citations

13.

Malik, Shipra & Raman Bahal. (2019). Investigation of PLGA nanoparticles in conjunction with nuclear localization sequence for enhanced delivery of antimiR phosphorothioates in cancer cells in vitro. Journal of Nanobiotechnology. 17(1). 57–57. 20 indexed citations

14.

Rad, Armin Tahmasbi, Shipra Malik, Lin Yang, et al.. (2019). A universal discoidal nanoplatform for the intracellular delivery of PNAs. Nanoscale. 11(26). 12517–12529. 26 indexed citations

15.

Malik, Shipra, et al.. (2019). Advances in Nanoparticle-based Delivery of Next Generation Peptide Nucleic Acids. Current Pharmaceutical Design. 24(43). 5164–5174. 14 indexed citations

16.

Malik, Shipra, et al.. (2018). Applications of PNA-laden nanoparticles for hematological disorders. Cellular and Molecular Life Sciences. 76(6). 1057–1065. 9 indexed citations

17.

Chauhan, Meenakshi Kanwar & Shipra Malik. (2016). REGULATORY GUIDELINES FOR APPROVAL OF BIOSIMILARS IN INDIA, EUROPE, BRAZIL AND CHINA: A COMPREHENSIVE OVERVIEW. International Journal of Pharmacy and Pharmaceutical Sciences. 8(10). 7–7. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact